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In sub-Saharan Africa, HIV, syphilis, malaria and anaemia are leading preventable causes
of adverse pregnancy outcomes. In Kenya, policy states women should be tested for all four
conditions (malaria only if febrile) at first antenatal care (ANC) visit. In practice, while HIV
screening is conducted, coverage of screening for the others is suboptimal and early preg-
nancy management of illnesses is compromised. This is particularly evident at rural dispen-
saries that lack laboratories and have parallel programmes for HIV, reproductive health and
malaria, resulting in fractured and inadequate care for women.
Methods
A longitudinal eight-month implementation study integrating point-of-care diagnostic tests
for the four conditions into routine ANC was conducted in seven purposively selected dis-
pensaries in western Kenya. Testing proficiency of healthcare workers was observed at ini-
tial training and at three monthly intervals thereafter. Adoption of testing was compared
using ANC register data 8.5 months before and eight months during the intervention. Fidelity
to clinical management guidelines was determined by client exit interviews with success
defined as90% adherence.
Findings
For first ANC visits at baseline (n = 529), testing rates were unavailable for malaria, low for
syphilis (4.3%) and anaemia (27.8%), and near universal for HIV (99%). During intervention,
over 95% of first attendees (n = 586) completed four tests and of those tested positive,
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70.6% received penicillin or erythromycin for syphilis, 65.5% and 48.3% received cotrimoxa-
zole and antiretrovirals respectively for HIV, and 76.4% received artemether/lumefantrine,
quinine or dihydroartemisinin–piperaquine correctly for malaria. Iron and folic supplements
were given to nearly 90% of women but often at incorrect doses.
Conclusions
Integrating point-of-care testing into ANC at dispensaries with established HIV testing pro-
grammes resulted in a significant increase in testing rates, without disturbing HIV testing
rates. While more cases were detected and treated, treatment fidelity still requires strength-
ening and an integrated monitoring and evaluation system needs to be established.
Background
In sub-Saharan Africa (SSA), the most preventable leading causes of maternal mortality and
adverse pregnancy outcomes are maternal HIV, syphilis, malaria and anaemia [1–4], with co-
infections common [5–9]. SSA has an estimated maternal HIV prevalence of 5.3%, represent-
ing 92% of the world’s HIV positive pregnant women [10, 11]. Roughly 24% of deaths in
women during pregnancy or post-partum are attributable to untreated HIV [1]. Maternal
syphilis in the African region has a prevalence of 1.7%, which constitutes 63.1% of infections
in pregnancy globally [2]. Syphilis is associated with spontaneous miscarriage, stillbirth, pre-
term birth, low birthweight, neonatal death, and congenital infection in infants [2]. The risk
for both HIV and syphilis mother-to-child transmission cumulates with duration of exposure
in utero [12, 13] and late treatments of syphilis may not avert damage to foetal development
[14]. Where malaria is endemic, 45% of pregnancies would be infected [3, 15]. Starting from
early gestation throughout, malaria parasitaemia is associated with anaemia, intrauterine
growth restriction, preterm delivery, foetal loss, neonatal and infant mortality [3, 16–19].
Anaemia is also most prevalent in Africa: about 46% of pregnant women are anaemic and
1.5% are severely anaemic [20]. Anaemia during pregnancy causes fatigue and is associated
with increased risk of post-partum haemorrhage, maternal mortality, low birth weight, and
perinatal mortality [21–23]. There is substantial evidence that iron deficiency early in preg-
nancy (first and second trimester) contributes to higher risk of pre-term delivery and lower
birth weight than if it occurred later [23, 24]. Thus, early prevention, diagnosis and treatment
is key to protect women and their pregnancies. Many of these conditions do not exist in isola-
tion and having one disease or condition may also be a risk factor for another: malaria is more
common in women with HIV [25–27]; risk of HIV transmission is increased through genital
ulcer disease [5]; malaria is a major risk factor for anaemia [28]; approximately 26% of severe
anaemia in pregnant women is attributable to malaria and can be reduced by 38% from pre-
venting malaria infection in pregnancy [3]. Because of their individual and combined contri-
bution to disease, addressing these conditions together, as early as possible during pregnancy
is an essential goal of antenatal care (ANC) [29].
Since 2001, Kenya has adopted the World Health Organization’s (WHO) focused ANC
guidelines which call for a minimum of four visits [30] (recently updated to eight ‘contacts’ by
WHO [29]). For the first visit, Kenyan guidelines recommend screening for HIV, syphilis and
anaemia, urinalysis, and blood typing (together known as the ANC profile). To prevent the
consequences of malaria in pregnancy, the current strategy recommends parasitic diagnosis of
malaria only if the patient is febrile, together with the use of insecticide-treated nets (ITNs)
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and ANC administered intermittent preventive therapy with sulfadoxine-pyrimethamine
(IPTp-SP). Expanding malaria testing at the first ANC visit to all pregnant women, regardless
of fever [31–33], may be an attractive strategy in parts of Africa for various reasons including
concerns about the impact of high grade SP resistance [34] or that some populations may no
longer require IPTp because of marked reductions in malaria transmission. Furthermore,
IPTp alone may be an inadequate intervention because women who attend ANC in the first
trimester are not eligible for SP, and the uptake of IPTp has been low, with only half of preg-
nant women receiving at least one of three or more recommended doses of SP [19, 35, 36].
Rates of testing for syphilis and anaemia remain low among pregnant women in Kenya
[37–39] even though 95% of pregnant women attend at least one ANC visit [40]. This is largely
because most women attend ANC at dispensaries (tier-2 health facilities in the periphery)
which do not typically stock diagnostic tests (except for HIV) and are referred, with additional
costs and time implications, to distant facilities with laboratory capacity to complete their
ANC profile [41, 42]. The difference in availability between tests for HIV and those for syphilis
and anaemia reflects the high international priority and substantial financial support given to
vertical HIV programmes resulting in parallel procurement and supervisory systems devel-
oped to ensure their accessibility and use [43, 44]. Syphilis and haemoglobin screening, despite
the strong evidence for their clinical effectiveness [45–47], lack such donor advocacy and pri-
oritization and suffer inadequate coverage [43, 44].
Affordable and reliable rapid point-of-care tests (POCTs) that require minimal training
and equipment are available to fulfil antenatal screening requirements. Their simplicity and
immediacy of results greatly benefit resource-constrained settings by allowing same-day initia-
tion of management of conditions and their co-infections. POCTs have been instrumental in
the scale-up of prevention of mother-to-child-transmission (PMTCT) of HIV services, achiev-
ing over 90% of HIV testing coverage in women who attend ANC [40]. The skills healthcare
workers have gained from HIV testing can be expanded to integrate the use of POCTs for
syphilis, malaria and anaemia at dispensaries so coverage of diagnosis and timely treatment
can be improved.
This longitudinal implementation study quantitatively evaluated the adoption and fidelity
of a programme intervention integrating point-of-care testing (POCT) for HIV, syphilis,
malaria and anaemia at ANCs in dispensaries in western Kenya. We evaluated whether inte-
grated POCT can increase the proportion of pregnant women tested and treated correctly for
each of the respective conditions at first ANC visit. Other implementation outcomes of appro-
priateness, acceptability and feasibility will be reported elsewhere.
Methods
Study setting
The study was conducted between December 2014 and August 2015 in the site of the KEMRI
and CDC Health and Demographic Surveillance System (HDSS) in Siaya County, western
Kenya. The population is 95% ethnically Luo, rural, and lives through subsistence farming and
local trading [48]. At the time of the study, there were 37 public health facilities in the study
area: one district hospital, nine health centres and 27 dispensaries. Dispensaries comprise the
lowest level (tier-2) of the formal health system and offer basic maternal and child health ser-
vices, rudimentary out-patient curative care and support care for HIV positive patients. Per-
sonnel typically include one to two nurses trained to certificate (at least 30 months training
post-secondary) or diploma level (at least 36 months training post-secondary), a part-time
clinical officer (36 months training post-secondary), an HIV testing counsellor and some sup-
port staff. The dispensaries receive approximately 40 antenatal visits per month.
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Health facility evaluations pre-intervention
Initial facility assessments were conducted to assess capacity to offer POCTs in nine health
centres and 24 dispensaries within the HDSS area (three dispensaries were not assessed). Facil-
ity evaluation covered information such as facility infrastructure, client load, number and type
of antenatal health workers, testing services and client flow. The assessment used a survey and
observation checklist adapted from the Demographic and Health Surveys (DHS) Program
[49]. Instruments were pre-tested outside the catchment area and were carried out by trained
data collectors.
Seven dispensaries were then purposively selected for inclusion in the study based on the
following criteria: absence of other ongoing studies with pregnant women, geographic spread
within the visual map area of HDSS, the number of monthly antenatal visits identified through
retrospective register review, and willingness of the facility to participate. All seven facilities’
ANC clinics routinely conducted HIV testing, two irregularly conducted anaemia testing, and
three irregularly conducted malaria testing. Lack of test supplies was the main reason for not
conducting ANC testing for syphilis and anaemia.
Implementation of programme
Integration here is defined as provision of all four tests concurrently, by a single healthcare
worker, during a woman’s first ANC visit. In facilities that have specialized HIV testing coun-
sellors, the four tests may be done by the counsellor instead of the ANC nurse. All the facilities’
ANC healthcare workers were given a competency-based training either at a central location
or on-site. All participants received training manuals and job aid testing placemats with step-
by-step instructions (S1 Fig). Training included using one finger-prick blood draw to run all
four tests per standard operating procedures, safety, and appropriate preventive care and clini-
cal management of positive results following Kenyan guidelines as summarised in Table 1:
Study facilities used existing HIV drugs and HIV POCTs supplied by the Government of
Kenya per its standard national algorithm at the time: HIV (1+2) Antibody Colloidal Gold
(KHB, Shanghai Kehua Bio-engineering Co Ltd, China) for screening, First Response HIV-1-2
kits (Premier Medical Corporation Ltd., Kachigam, India) for confirmation and Uni-Gold™
(Trinity Biotech, Ireland) for tie-breaking. Iron, folic acid, SP and malaria treatment drugs
were also supplied free of charge by the government. The study supplied the facilities with
Table 1. Appropriate clinical management for positive test results and preventive care at first ANC visit [50].
Condition For treatment For prevention
HIV Initiate PMTCT; counsel; give cotrimoxazole and start triple therapy with
antiretrovirals
Syphilis Provide single dose of 2.4 MU benzathine penicillin or if penicillin allergic
and unable to access penicillin desensitization, give erythromycin 500 mg
three times daily for seven days and counsel on partner notification
Malaria Uncomplicated malaria: give quinine in first trimester; give artemether/
lumefantrine (AL), quinine or dihydroartemisinin-piperaquine (DP) in
second or third trimester; clinical severe malaria: refer to hospital
Give directly observed IPTp-SP for malaria for women in second or third
trimester not on cotrimoxazole; give ITN and advise to sleep under it.
Anaemia Mild anaemia (Hb <10 g/dL): give 120 mg daily elemental iron; moderate
anaemia (Hb 5–7.9 g/dL): as above and provide additional iron dextran;
severe anaemia (Hb is <5 g/dL): refer to hospital
Not anaemic (Hb >10 g/dL): give 65 mg daily elemental iron
Neural tube
defects
Low dose (0.4 mg) folic acid daily; if low dose folic acid is not available,
high dose (5 mg) tablets should not be administered with SP but can be
taken 14 days following administration of IPTp-SP.
ANC: antenatal care; POCT; point-of-care testing; PMTCT: prevention of mother-to-child transmission; IPTp-SP: intermittent preventive therapy in pregnancy with
sulfadoxine-pyrimethamine; ITN: insecticide-treated net
https://doi.org/10.1371/journal.pone.0198784.t001
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POCTs for syphilis (SD BIOLINE Syphilis 3.0 test for antibodies against Treponema pallidum,
Standard Diagnostic Inc., Korea), malaria (CareStart™ Malaria HRP2 Pf, AccessBio, USA) and
haemoglobin concentrations (HemoCue1 Hb 201+, HemoCue AB, Sweden) and ensured no
stock-outs. For each lot number, 1% of the tests were selected at random and validated at
KEMRI/CDC’s HIV reference laboratory in Kisumu, western Kenya, using known positive
and negative samples. HemoCue1 machines were calibrated every three months. The study
also provided BrannanTM triple timers, gloves, and benzathine penicillin for treating syphilis
based on projected prevalence of syphilis in the area.
Data collection and outcome indicators
Photographs of routine ANC registers were taken for 8.5 months before and eight months during
intervention and the data were double-entered into the study database. There was no distinct col-
umn for recording malaria results in the registers so no reliable data existed pre-intervention and
a column was added to facilitate collection of malaria test results during the intervention. From
the registers, testing uptake was assessed among women aged 15–49 years below 28 gestational
weeks of pregnancy (<28gw) attending their first ANC visit. The gestational age was estimated
using date of last menstrual period (LMP) or fundal height if LMP was unknown. The evaluation
was done in this group of women because adverse pregnancy outcomes are most preventable with
early treatment and so we concentrated on outcomes in this population.
During the intervention, these women were also asked to participate in exit interviews with
trained research staff following their visits. Written informed consents were obtained. For illit-
erate women, the consent forms were read to the women in the presence of a literate witness
and verbal consents with thumb prints and witness signatures were obtained. Women who
refused to participate or were unable to provide informed consent because of mental or physi-
cal disability were excluded. Those who consented were interviewed for 20–30 mins in a pri-
vate area at the facility. Interviews asked whether women were given information about the
blood tests, test results, any preventive care or treatments (including detailed information on
type and dosage of drugs not captured by ANC registers) using picture cards or observed
drugs by interviewers, counselling, and advice for partner notification.
Quality assessments (QA) through observed proficiency testing of healthcare workers to
correctly perform rapid tests per manufacturers’ instructions were done immediately after ini-
tial training and at three, six and nine months (shortly after eight months of the intervention)
using a 57-step checklist (S1 Text) by trained research staff. Those who performed90% of
the checklist correctly received reminders for any missed steps and proceeded to implement
integrated POCT. Those who did not reach90% were re-trained until proficient.
Endpoints for assessing programme adoption and implementation fidelity are summarised
in Table 2. Adoption is defined as “the action to try or employ an innovation. . .also may be
referred to as ‘uptake’” and fidelity is defined as the “degree to which [the] intervention was imple-
mented as intended by program developers and the quality of program delivery” [51]. Success was
set at90% in line with global testing and treatment targets for HIV and syphilis [52, 53]. Degrees
of under-reaching the success target were categorised as follows: under-reached 60% to<90%,
very under-reached 40% to<60% and severely under-reached<40%. Because introducing new
services may affect existing services, synergy of integrating POCT with HIV testing was deter-
mined by change of HIV testing rates before and after the intervention.
Data analysis
Quantitative data were entered in Microsoft Excel 2016. Descriptive statistics and analyses
were done in Stata 14. The command metan was used to graphically display before and during
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testing proportions. For categorical variables, proportions were calculated and Chi2 was used
to test for associations. For non-normal distributions of continuous data, medians and inter-
quartile ranges (IQR) were calculated and Wilcoxon rank-sum tests were used to test for asso-
ciations. Box and whisker plots of proficiency tests scores were created in Microsoft Excel
2016. Using individual and facility level variables collected from the study, we explored factors
associated with women not having a complete testing profile. Relative risks of having an
incomplete ANC profile were obtained for each variable by fitting a log-binomial generalized
estimating equation model that took facility clustering into account. Variables that had a sig-
nificance level of<0.20 in the univariate analysis were considered for inclusion. Multicolli-
nearity of selected variables was tested by using the variance inflation factor (VIF) command
in Stata. Variables with a tolerance value (1/VIF) <0.1 were considered collinear with one of
the other independent variables.
Ethical considerations
The protocol was reviewed and approved by the scientific and ethical steering committees of
the Kenya Medical Research Institute (protocol 2271) and the Liverpool School of Tropical
Medicine Ethics Committee (protocol 14.017). For U.S. CDC, while this activity was deter-
mined to be human subjects research, CDC staff involvement did not constitute engagement
in human subjects’ research, thus not requiring human subjects research review by the CDC
institutional review board.
Results
Increase in testing uptake (ANC register data)
During 8.5 months before the integrated POCT programme, the seven facilities received 2279
ANC visits (median: 37, IQR: 28–37 visits per month) and 698 of them (median: 11, IQR: 8–11
visits per month) were first visits. Of the first visits, 529 (75.7%) women were<28gw and aged
15–49 years. During the eight months of integrated POCT programme, 2240 ANC visits were
made at the seven facilities (median: 38, IQR: 32–38 visits per month). Of these, 728 were first
ANC visits (median: 13, IQR: 10–13 visits per month), and 586 (80.5%) were by women
<28gw aged 15–49. HIV testing rates remained over 90% in all facilities both before and dur-
ing integrated POCT period. For syphilis and anaemia, overall testing proportions increased
from 4.3% (mean: 5.4%, SD: 4.0%, range: 0–12.5%) and 27.8% (mean: 25.9%, SD: 29.8%,
Table 2. Indicators of adoption, fidelity, and proposed success endpoints [51].
Indicators of adoption and fidelity Indicator measure Data source Success endpoints
Adoption Testing uptake and synergy
into HIV programme
% of pregnant women tested for syphilis, malaria and anaemia by
POCTs; unchanged or improved % of women tested for HIV
ANC register  90% tested;0% change
in HIV testing rates
Fidelity Clinical management % of pregnant women who receive appropriate:
a) preventive care
b) correct management for test positive cases
Exit interviews 90% received
Information giving % of pregnant women who were given:
a) information about the four tests
b) test results
c) HIV counselling
d) syphilis partner notification advice
Exit interviews 90% given/counselled/
advised
Health worker proficiency of
POCT
Proficiency scores measuring the ability of the health care worker to




POCTs: point-of-care tests; POCT: point-of-care testing; ANC: antenatal care
https://doi.org/10.1371/journal.pone.0198784.t002
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range: 1.5–81.9%) respectively to over 97%. The variations in syphilis and anaemia testing pre-
intervention reflect the inconsistent availability of test supplies within and between facilities.
Facility one and seven had noticeably higher testing rates for anaemia because they received
test supplies from the district hospital and an external partner respectively. Malaria testing also
reached over 97% in all facilities during the intervention (Fig 1).
New infections and co-infections picked up by POCTs. Among the 529 pregnancies
evaluated pre-intervention, 31 new HIV infections, no syphilis infections, and 58 anaemic
women (Hb<10 g/dL) were detected. There were 78 women with known HIV positive statuses.
Among the 586 pregnancies during integrated POCT, 41 new HIV infections, 18 syphilis
infections, 177 malaria infections, and 223 anaemic women were detected. There were 77
women with known HIV positive statuses (Table 3). Among 118 HIV positive women, co-
infections with syphilis were found in five (4.2%) and with malaria in 30 (25.4%). Among 223
anaemic women, malaria was detected in 90 (40.4%). One woman tested positive for syphilis,
malaria and anaemia while none tested positive for all four conditions. Among HIV known
positives, one woman was tested syphilis positive and anaemic.
Mixed programme fidelity in management of conditions (self-reported
from exit interviews)
Among 586 pregnancies eligible for exit interviews, 106 (18.1%) did not consent. Those inter-
viewed were more likely to have had a previous miscarriage, or have been tested for malaria,
and were less likely to be newly diagnosed HIV positive (Table 3).
HIV. Of 29 women who were newly tested positive for HIV, treatment was commenced
that same visit for less than the 90% target: 19 (65.5%) were given CTX, and 14 (48.3%) were
given ARVs (Table 4). One woman was told to return the following day for treatment while
seven (24.1%) women refused treatment citing reasons such as: they should consult their hus-
bands; they will start therapy at other clinics; they need to confirm at other clinics; they did not
like the nurse’s attitude.
Syphilis. Among 441 women who self-reported receiving syphilis tests, 17 (3.9%) reported
positive results of which 12 (70.6%) were given either penicillin (n = 11) or erythromycin
(n = 1) the same day (Table 4). One woman was told to return the next day with her partner
for couples’ treatment and the remaining four were asked to buy penicillin or erythromycin at
a pharmacy even though the study had supplied the facilities with sufficient penicillin based on
projected prevalence. Thirteen women (76.5%) said they were advised by the nurse to inform
their partners (Table 5).
Treatment and IPTp-SP for malaria. Based on exit interviews, 469 women self-reported
receiving malaria tests of which 161 (34.3%) were positive. Among those with positive malaria
tests, eight were in their first trimester of whom two (25%) were given quinine and the rest
were given or prescribed AL or DP. Of the 153 malaria positive pregnancies in their second tri-
mester, 121 (79.1%) were given AL, DP, or quinine and the rest were given SP (n = 2), pre-
scribed quinine or AL (n = 24) or not given or prescribed anything (n = 6) (Table 4).
Therefore 123/161 (76.4%) were given antimalarials in accordance with treatment guidelines.
SP was out of stock for most of the integrated POCT period and only 76 women reported
receiving SP for IPTp. Of these, seven were given high dose (5 mg) folic acid concurrently,
which is not compliant with guidelines for women receiving IPTp-SP (Table 4). Of the women
eligible for SP (in second trimester and not on cotrimoxazole), 19.2% (69/359) received IPTp-
SP (Table 4).
Anaemia and haematinic supplementation. Among 480 women interviewed, 434
(90.4%) received iron supplementation. However, the reported dosing regimen did not adhere
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to prophylactic or treatment guidance based on Hb concentrations recorded in the ANC regis-
ter (Table 4). None of the interviewed women had severe anaemia and six (13.3%) of 45 with
moderate anaemia were asked to buy iron dextran. Folic acid was given to 421 (87.7%) women
in either 0.4 mg folic-iron combination tablets or 5 mg tablets (Table 4).
Information giving. General information and advice given to women about the four con-
ditions is shown in Table 5. Over 90% reported they received the blood tests. Furthermore,
over 90% reported test results for HIV, syphilis and malaria that were concordant with those
from the ANC register, while only half of those tested for Hb reported anaemia statuses that
agreed with those from the register (Table 5). Women who reported not being told results for
HIV, syphilis, or malaria were all negative for those conditions based on the ANC register.
Healthcare worker training, turnover, and performance
Overall 23 healthcare workers (14 nurses: eight females, six males; two clinical officers: two
males; six HIV testing counsellors: one female, five males; and one laboratory technician:
female) received training and underwent at least one testing QA. All nurses were trained to
certificate or diploma level through the government system. Fourteen (60%) of the healthcare
workers attended central trainings (eight were trained for five days in November and six for
three days in February for those who were unable to make it in November), while nine (40%)
received half-day on-site trainings. Turnover of staff was high: of the 16 original healthcare
workers at the beginning of the study, only 10 remained by the end of the eight months. Seven
new healthcare workers transferred to the facilities during the study and remained until the
end. The predictor model suggested that high turnover (adjusted for age, marital status and
electricity) was associated with a three-fold increased risk of antenatal women not having a full
screening profile (Table 6).
Due to turnover and new staff joining, 18 received at least two QAs, 16 received three, 13
received four and two received five. Out of a total of 72 QA scores, 20 (28.6%), belonging to 15
healthcare workers, were below 90% and required more intensive re-training on the same day
for steps such as obtaining enough blood from one finger-prick, correctly using the pipette
and how to set the timer. Seven of the 15 were evaluated again within a month. Minimum
scores improved over the proficiency tests from 70% to 91%. Distribution of scores from the
QAs are shown as box and whisker plots in Fig 2. The results of the five QAs suggested that
most healthcare workers could accurately conduct integrated POCT after training and reme-
dial training.
Discussion
This is the first intervention study to evaluate the implementation success of integrating four
POCTs into ANC in rural dispensaries in western Kenya. We showed a substantial increase in
testing for syphilis, malaria and anaemia that provided an opportunity for the improved man-
agement of these conditions in a context of a well-established HIV rapid testing programme in
pregnancy. Our results suggest that integrated POCT increases the number of cases detected
and treated at the first antenatal visit in these small rural dispensaries without distortion of
HIV testing which remained near universal throughout. Despite the management of condi-
tions not reaching our target of 90% fidelity to guidelines, we suspect the treatment for syphilis,
Fig 1. Proportion tested for condition pre (n = 529) and during (n = 586) integrated POCT programme by facility. No data on number of women tested for
malaria were available from the antenatal care registers before the intervention and therefore pre- and post-proportions were not comparable; ^profile pre-
integrated POCT includes HIV, syphilis and anaemia; profile during integrated POCT includes HIV, syphilis, malaria and anaemia; POCT: point-of-care testing;
RD: risk difference, interpreted as the difference in testing proportions before and during integrated POCT.
https://doi.org/10.1371/journal.pone.0198784.g001
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Table 3. Test positivity rates and demographic characteristics of women aged between 15–49 years and<28 weeks pregnant, based on data from ANC registers 8.5
months before and 8 months during integrated POCT programme.
Conditions Before integrated
POCT (n = 529)
During integrated POCT (n = 586)
All All Not interviewed n = 106 Interviewed n = 480 P-value
HIV n = 529 n = 585 n = 105 n = 480
known positive 78/529 (14.7%) 77/585 (13.2%) 16/105 (15.2%) 61/480 (12.7%) 0.487
tested for HIV 448/451 (99.3%) 504/508 (99.2%) 87/89 (97.8%) 417/419 (99.5) 0.087
tested positive 31/448 (6.9%) 41/504 (8.1%) 12/87 (13.8%) 29/417 (7.0%) 0.034
total HIV positive 109/526 (20.7%) 118/581 (20.3%) 28/103 (27.2%) 90/478 (18.8%)
Syphilis n = 529 n = 586 n = 106 n = 480
tested for syphilis 23/529 (4.3%) 572/586 (97.6%) 102/106 (96.2%) 470/480 (97.9%) 0.302
tested positive 0/23 (0%) 18/572 (3.1%) 2/102 (2%) 16/470 (3.4%) 0.449
Malaria n = 562 n = 105 n = 457
tested for mal 554/562 (98.6%) 100/105 (95.2%) 454/457 (99.3%) 0.001
tested positive 177/554 (31.9%) 28/100 (28%) 149/454 (32.8%) 0.349
Anaemia (g/dL) n = 529 n = 582 n = 106 n = 476
tested for Hb conc. 147/529 (27.8%) 569/582 (97.8%) 101/106 (95.3%) 468/476 (98.3%) 0.056
Non-anaemic Hb 10 g/dL 89/147 (60.5%) 346/569 (60.8%) 60/101 (59.4%) 286/468 (61.1%)
Mild Hb 8–9.9 g/dL 46/147 (31.3%) 166/569 (29.2%) 29/101 (28.7%) 137/468 (29.3%)
Moderate Hb 5–7.9 g/dL 12/147 (8.2%) 56/569 (9.8%) 11/101 (10.9%) 45/468 (9.6%)
Severe Hb <5 g/dL 0/147 (0%) 1/569 (0.2%) 1/101 (1%) 0/468 (0%) 0.185
WHO anaemic Hb <11 g/dL 91/147 (61.9%) 346/569 (60.8%) 65/101 (64.4%) 281/468 (60%)
Demographics During integrated POCT (n = 586)
All Not interviewed n = 106 Interviewed n = 480 P-value
Age n = 585 n = 106 n = 479
<20 159 (27.2%) 30 (28.3%) 129 (26.9%)
20 to <25 208 (35.6%) 40 (37.7%) 168 (35.1%)
25 to <30 118 (20.2%) 18 (17%) 100 (20.9%)
30 to <35 64 (10.9%) 12 (11.3%) 52 (10.9%)
35+ 36 (6.2%) 6 (5.7%) 30 (6.3%) 0.917
Gestation in weeks n = 583 n = 106 n = 477
median (IQR) 21.1 (16.9–24.1) 21.7 (17.6–24.4) 21.1 (16.9–24.1) 0.47a
Gravidity n = 586 n = 106 n = 480
gravida 1 163 (27.9%) 38 (35.8%) 125 (26.1%)
gravida 2 134 (22.9%) 24 (22.6%) 110 (23%)
gravida 3 114 (19.5%) 14 (13.2%) 100 (20.9%)
gravida 4 70 (12%) 12 (11.3%) 58 (12.1%)
gravida 5+ 105 (17.9%) 18 (17%) 87 (18.1%) 0.22
Previous miscarriage n = 586 n = 106 n = 480
Yes 21 (3.6%) 0 (0%) 21 (4.4%) 0.028
Marital status n = 586 n = 106 n = 480
married 466 (79.5%) 83 (78.3%) 383 (79.8%)
widowed 9 (1.5%) 2 (1.9%) 7 (1.5%)
single 93 (15.9%) 15 (14.2%) 78 (16.3%)
divorced/separated 18 (17.2%) 6 (5.9%) 12 (12%) 0.363
WHO Hb: World Health Organization standards for haemoglobin cut-offs for defining anaemia else Kenyan cut-offs
p-value based on Chi2 for the difference between those interviewed and not interviewed
a: p-value based on Wilcoxon rank-sum for the difference in median between those interviewed and not interviewed
ANC: antenatal care; POCT: point-of-care testing; Hb: haemoglobin concentration
https://doi.org/10.1371/journal.pone.0198784.t003
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Table 4. Self-reported treatments for test positives, IPTp for malaria, and haematinic supplementation given at first visit ANC among 480 interviewed women.
Proportion Success threshold Target reached for correct ANC strategies? 
HIV treatment
Given CTX 19/29 (65.5%) 90% Under-reached
Given ARVs 14/29 (48.3%) 90% Very under-reached
Syphilis treatment
Given 2.4 MU benzathine penicillin or erythromycin 12/17 (70.6%) 90% Under-reached
Malaria intermittent preventive therapy and treatment
Given SP for IPTp among women in 2nd trimester not on CTX† 69/359 (19.2%) 90% Severely under-reached
Given SP for IPTp among women in 1st trimester not on CTX† 5/41 (12.2%)
Given SP to women also on CTX‡ 2/80 (2.5%)
Given 5 mg folic acid with SP 7/76 (9.2%)
Given AL, DP or quinine among malaria positives in 2nd trimester 121/153 (79.1%) 90% Under-reached
Given quinine among malaria positives in 1st trimester 2/8 (25%) 90% Severely under-reached
Haematinic supplementation for prophylaxis and treatment
Given folic acid 421/480 (87.7%) 90% Under-reached
- Told to take between 0.4–1.2 mg daily 378/421 (89.8%)
- Told to take between 5–10 mg daily 43/421 (10%)
Given iron 434/480 (90.4%) 90% Reached
- Given iron and mentioned side effects 41/434 (9.4%) 90% Severely under-reached
Iron dosing information given to women according to Hb level
Normal Hb10 g/dL n = 286
- 60–65 mg elemental iron daily 193/286 (67.4%) 90% Under-reached
- 120–130 mg elemental iron daily 4/286 (1.4%)
- 180–195 mg elemental iron daily 49/286 (17.1%)
- Not told dosing 12/286 (4.2%)
- Not given any iron 28/286 (9.8%)
Mild anaemia Hb 8–9.9 g/dL n = 137
- 60–65 mg elemental iron daily 86/137 (62.8%)
- 120–130 mg elemental iron daily 4/137 (2.9%) 90% Severely under-reached
- 180–195 mg elemental iron daily 32/137 (23.4%)
- Not told dosing 3/137 (2.2%)
- Not given any iron 12/137 (8.8%)
Moderate anaemia Hb 5–7.9 g/dL n = 45
- 60–65 mg elemental iron daily 20/45 (44.4%)
- 120–130 mg elemental iron daily 9/45 (20%) 90% Severely under-reached
- 180–195 mg elemental iron daily 9/45 (20%)
- Not told dosing 2/45 (4.4%)
- Not given any iron 5/45 (11.1%)
No Hb recorded n = 12
- 60–65 mg elemental iron daily 8/12 (66.7%)
- 120–130 mg elemental iron daily 1/12 (8.3%)
- Not told dosing 2/12 (16.7%)
- Not given any iron 1/12 (8.3%)
 90% target reached, <90% to60—under-reached, <60% to40 very under-reached, <40% severely under-reached
IPTp: intermittent preventive therapy in pregnancy; ANC: antenatal care; CTX: cotrimoxazole; ARV: antiretroviral; SP:sulfadoxine-pyrimethamine; AL: artemether/
lumefantrine; DP: dihydroartemisinin-piperaquine (DP); Hb: haemoglobin concentration
†not on CTX includes women who were tested HIV negative, unknown status, and new positive but were not given CTX same day
‡on CTX includes known HIV positives and new HIV positives who were given CTX same day
https://doi.org/10.1371/journal.pone.0198784.t004
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malaria and anaemia represented a laudable improvement from baseline. By bringing POCTs
to peripheral dispensaries, accessibility and coverage of these tests for pregnant women resid-
ing in remote areas, who were otherwise not able to access testing at larger facilities farther
away, was significantly improved.
Table 5. Self-reported information given about the tests at first ANC visit among 480 interviewed women.
Proportion Success threshold Target reached for correct ANC strategies?
Information about HIV
Received HIV counselling 167/480 (34.8%) 90% Severely under-reached
Reported receiving an HIV test among those who had an HIV 411/417 (98.6%) 90% Reached
test result in ANC register
Reported told HIV status that 399/411 (97%) 90% Reached
agree with result in ANC register
Reported told HIV status that did not 0/411 (0%)
agree with result in ANC register
Reported not told any results for HIVa 12/411 (2.9%)
Information about syphilis
Explained what syphilis is 83/475 (17.5%) 90% Severely under-reached
Reported receiving a syphilis test among those who had a 438/470 (93.2%) 90% Reached
syphilis test result in ANC register
Reported told syphilis status that 417/438 (95.2%) 90% Reached
agree with result in ANC register
Reported told syphilis status that did not agree 2/438 (4.6%)
with result in ANC register
Reported not told any results for syphilisa 19/438 (4.3%)
Advised to inform partners of syphilis positivity 13/17 (76.5%) 90% Under-reached
Information about malaria
Given advice to use mosquito net to prevent malaria 346/478 (72.4%) 90% Under-reached
Given a mosquito net (n = 349) 331/349 (94.8%) 90% Reached
Reported receiving a malaria test among those who had a 445/454 (98%) 90% Reached
malaria result in ANC register
Reported told malaria status that 420/445 (94.4%) 90% Reached
agree with result in ANC register
Reported told malaria status that did not agree 11/445 (2.5%)
with result in ANC register
Reported not told any results for malariaa 14/445 (3.1%)
Information about anaemia
Given advice to eat food with iron 132/480 (27.5%) 90% Severely under-reached
Explained what anaemia is 107/480 (22.3%) 90% Severely under-reached
Reported receiving an anaemia test among those who had an 448/468 (95.7%) 90% Reached
Hb result in ANC register
Reported told an anaemia status that 235/448 (52.5%) 90% Very under-reached
agree with Hb level in ANC register
Reported told an anaemia status that 60/448 (13.4%)
did not agree with Hb level in ANC register
Reported not told any results for anaemia test 153/448 (34.2%)
 90% target reached, <90% to60 under-reached, <60% to40 very under-reached, <40% severely under-reached
ANC: antenatal care; Hb: haemoglobin concentration; KP: known HIV positives
a: Women reported not told results for HIV, syphilis or malaria were all negative based on ANC registers
https://doi.org/10.1371/journal.pone.0198784.t005
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Table 6. Predictors of pregnant women not having a full antenatal screening profile at first visits (n = 728).
Univariate analysis Multivariate model
Individual-level
variables
n = 728 Women without full profile in
ANC register
RR (95% CI) of not having a full
profile in ANC register
p-value RR(95% CI) of not having a full
profile in ANC register
p-value
Age in years 0.003
30 143
(19.6%)
6 (4.2%) Reference Reference
 20 to <30 398
(54.7%)
46 (11.6%) 2.7 (1.5–4.8) 2.9 (1.7–4.9) <0.0001
< 20 187
(25.7%)






6 (5.2%) Reference Reference
married 579
(79.6%)
59 (10.2%) 2.4 (1.2–5.0) 2.6 (1.5–4.7) 0.001







17 (10.8%) 1.1 (0.5–2.4)
3+ 377
(51.8%)




















27 (6.1%) Reference Reference
medium 151
(20.7%)
20 (13.3%) 2.2 (0.8–6.1) 1.9 (0.6–5.6) 0.253
high 131
(18.0%)







19 (6.4%) 0.5 (0.2–1.6)
high 280
(38.5%)
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Table 6. (Continued)
Univariate analysis Multivariate model
3 167
(22.9%)
19 (11.4%) 1.5 (0.4–5.5)
4 355
(48.8%)




3 (3.3%) Reference Reference
present 637
(87.5%)
67 (10.5%) 3.3 (2.0–5.5) 2.1 (1.2–3.7) 0.01
Wald test
n = 727
a: Staff turnover was categorized into low, medium and high defined as having 2, 1, and 0 skilled healthcare workers who received training at the start of the programme
and remained for all 8 months of implementation respectively
b: Facility volume was split into low, medium, and high for <30, 30–40, and 50–70 monthly ANC visits respectively
c: Skilled staff was defined as the total number of nurses, clinical officers, and HIV testing counsellors the facility had
ANC: antenatal care; RR: relative risk
https://doi.org/10.1371/journal.pone.0198784.t006
Fig 2. Proficiency scores (%) of healthcare worker checklists in point-of-care testing. The boxes represent interquartile ranges (25% to 75% percentile); the solid line
in the box is the median (50th percentile); The lower and upper whiskers represent the minimum and maximum values, excluding outlier; the dots represent outliers,
defined as values less than 1.5 times the lower quartile.
https://doi.org/10.1371/journal.pone.0198784.g002
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We found prevalence rates of 20.3%, 3.1%, 31.9%, and 60.8% for HIV, syphilis, malaria, and
anaemia (WHO cut-off Hb<11 g/dL, or 39.2% when using Kenyan guideline cut-offs of<10
g/dL) respectively, consistent with those reported in other studies [33, 39, 40, 54, 55]. Siaya is
about 1,200 meters above sea level and the altitude adjusted prevalence of anaemia using the
WHO cut-off was 70% [56].
The success of near universal HIV screening in ANC in Kenya, as reflected in our baseline
and intervention data, is the result of concerted vertical program efforts and external partner-
ships [57–59]. Although WHO has endorsed an integrated disease approach to service delivery
of antenatal care [60, 61], development assistance for HIV activities has risen disproportion-
ately since 2000 compared to assistance for other sexual reproductive health activities [62],
shifting agendas and priorities away from strengthening systems and building linkages
between programmes [44, 59, 63–65]. Funds are often earmarked for specific purposes with
deliverables defined by coverage and uptake, creating strong incentives for focused vertical
programmes that result in rapid outputs rather than overall health system improvement [63,
66, 67]. In Kenya, less than half of the pregnant women attending ANC are tested for syphilis
or haemoglobin concentrations [37–39, 68], even though antenatal screening is a major coun-
try policy and over 90% of pregnant women attend ANC [40]. These gaps can likely be reduced
by combining funding to support comprehensive ANC programmes and better coordination
mechanisms at national and county levels among the National AIDS and STI Control Pro-
gramme, the Department for Reproductive Health and the National Malaria Control Pro-
gramme [42, 69]. For malaria, there is currently no national recommendation for screening at
the first antenatal clinic visit, but this is commonly practiced in most of the larger facilities
with laboratories in the highly malaria endemic areas in western Kenya. Furthermore, there is
an increasing interest in this hybrid strategy that combines IPTp-SP with testing at the first
visit because of concerns about missed opportunities with IPTp and increasing SP resistance.
A quarter of newly diagnosed HIV positive women declined immediate treatment. This low
uptake of ARVs is consistent with the finding of a meta-analysis in 2012 that reported only
73.5% of pregnant women in low, middle and high-income countries achieved optimal adher-
ence to ARV therapy during and after pregnancy [70]. Quality of HIV counselling, lack of
emphasis of the importance of ARV adherence at post-test counselling, lack of male involve-
ment, and lack of trust of ANC staff are reasons reported to be associated with low adherence
[70]. In our study, we found low HIV counselling rates, which could explain why many
women were unprepared for positive results [71]. Dosing of iron among healthcare workers at
the seven dispensaries was not consistent and did not follow the national guidelines for iron
supplementation. These inconsistencies have also been highlighted in government surveys
conducted in 2013 which reported a lack of consistency in implementation of haematinic sup-
plementation at health facilities, poor knowledge of dosing and duration, inadequate knowl-
edge given to pregnant women about anaemia, low adherence and compliance, and limited
understanding of side effects leading to discontinuation [68]. The uptake of IPTp-SP was very
low or the intervention was incorrectly implemented, mostly because of stock-outs and poor
understanding of guidelines, falling well short of the target for 80% coverage by 2016 [72].
Poor IPTp-SP program implementation by health providers, stemming from unclear guide-
lines, stock-outs, poor facility organization, and low provider knowledge, had been reported
elsewhere [36, 73]. Case-management of malaria test-positive cases was much better than
IPTp-SP coverage, with almost 80% of women receiving treatment with an ACT or quinine.
Consistent with a previous study in this area by Riley et al [74], adherence to the national case-
management guidelines for women in the first trimester was inadequate and most women
were prescribed ACTs instead of the first line treatment with quinine. Starting in 2013 and
during the integrated POCT study period, Kenya was devolving the healthcare system and
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transferring authority for decision making, finance and management of health commodities to
the county level. This resulted in a disruption of the malaria commodity supply chain during
this transition period and corresponding stock-outs of SP and antimalarials, which may
explain some of these findings.
Ensuring all healthcare workers were trained to standard and have quality maintained over
time was challenging. High turnover of staff meant on-site training of new staff would pose
challenges if the intervention were to scale in real-life conditions unless training for POCTs
were incorporated into nursing school or was done on a country-level. Small, focused trainings
with interactions are more effective than didactic ones and will require time and planning
[75]. Since healthcare worker behaviours are complex with many contextual and environmen-
tal influencers, single, one-off interventions such as trainings or dissemination of guidelines
are less effective than routine supervisions and feedback to maintain high-quality performance
[75]. Quality improvement (QI) strategies that are step-wise, iterative, locally grown and
adapted to existing systems may be more appropriate for long-term sustainability but context
specific strategies need to be cultivated and effectiveness monitored in real-time [75–77].
There are several limitations to our study. We did not randomly sample the facilities and
therefore they may not be representative of all tier-2 facilities in the region. The evaluation
excluded women who attended their first ANC visits in the third trimester, which was about
20% of first ANC attendees. While they also received the same services as first and second tri-
mester women, their late attendance precludes early management of conditions and interven-
tions would be needed to address this population. We used routinely collected ANC register
data to calculate testing uptakebut there were inconsistencies in how the registers were filled.
For example, there were no columns for recording malaria test results in the existing ANC reg-
ister and so we hand-drew a column during the study period. This was not always communi-
cated to rotating ANC staff which resulted in 23 missing records for malaria testing. ANC
registers do not record treatment and so we relied on interviews with women to obtain infor-
mation on treatments and there were minor incongruences between self-reported and register
recorded test results. More effort is needed to ensure accurate record keeping. Exit interviews
were done with women at the facility immediately after an ANC visit; while this minimizes
recall bias, women may be less inclined to report on negative experiences or give perceived
acceptable responses without having understood the questions fully (courtesy bias). We did
not assess the continuum of clinical management fidelity at revisits or at delivery. For example,
new-borns of women given erythromycin for syphilis need to be treated immediately with a
regimen of penicillin injections [78] but this was not measured. Effort would be needed to
ensure healthcare worker’s understanding and adherence to clinical management throughout
the pregnancy and perinatal period. This study assessed clinical practice at the service delivery
stage of the implementation pathway [43] where the conditions of having test supplies avail-
able, training and supervision were met through provision by the study. To effect positive
health outcomes, wider health system concerns of supply chains, stock-outs and human
resource management would need to be addressed.
Conclusion
This study showed near universal HIV testing in rural dispensaries that lack laboratory facili-
ties and increased uptake of testing for syphilis, malaria and anaemia following training and
availability of POCTs. However, poor clinical management of conditions, frequent staff turn-
over and inadequate information given to pregnant women remain significant challenges that
will require integrated funding channels and a robust quality assurance programme to ensure
that standards are achieved and maintained in these peripheral facilities.
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